
<resource xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:datacite="http://datacite.org/schema/kernel-4" xmlns="http://namespace.openaire.eu/schema/oaire/" xsi:schemaLocation="http://namespace.openaire.eu/schema/oaire/ https://www.openaire.eu/schema/repo-lit/4.0/openaire.xsd">
  
<datacite:identifier identifierType="URL">https://phaidra.vetmeduni.ac.at/o:4046</datacite:identifier>

  
<datacite:titles>
  
<datacite:title xml:lang="en">YAP1 is a key regulator of EWS::FLI1-dependent malignant transformation upon IGF-1-mediated reprogramming of bone mesenchymal stem cells</datacite:title>

  
</datacite:titles>

  
<datacite:creators>
  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Noorizadeh, Rahil</datacite:creatorName>

  
<datacite:givenName>Rahil</datacite:givenName>

  
<datacite:familyName>Noorizadeh</datacite:familyName>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Sax, Barbara</datacite:creatorName>

  
<datacite:givenName>Barbara</datacite:givenName>

  
<datacite:familyName>Sax</datacite:familyName>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Javaheri, Tahereh</datacite:creatorName>

  
<datacite:givenName>Tahereh</datacite:givenName>

  
<datacite:familyName>Javaheri</datacite:familyName>

  
<datacite:nameIdentifier nameIdentifierScheme="ORCID" schemeURI="https://orcid.org/">0000-0001-6686-5574</datacite:nameIdentifier>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Radic-Sarikas, Branka</datacite:creatorName>

  
<datacite:givenName>Branka</datacite:givenName>

  
<datacite:familyName>Radic-Sarikas</datacite:familyName>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Fock, Valerie</datacite:creatorName>

  
<datacite:givenName>Valerie</datacite:givenName>

  
<datacite:familyName>Fock</datacite:familyName>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Suresh, Veveeyan</datacite:creatorName>

  
<datacite:givenName>Veveeyan</datacite:givenName>

  
<datacite:familyName>Suresh</datacite:familyName>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Kauer, Maximilian</datacite:creatorName>

  
<datacite:givenName>Maximilian</datacite:givenName>

  
<datacite:familyName>Kauer</datacite:familyName>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Bykov, Aleksandr</datacite:creatorName>

  
<datacite:givenName>Aleksandr</datacite:givenName>

  
<datacite:familyName>Bykov</datacite:familyName>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Kurija, Danijela</datacite:creatorName>

  
<datacite:givenName>Danijela</datacite:givenName>

  
<datacite:familyName>Kurija</datacite:familyName>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Schlederer, Michaela</datacite:creatorName>

  
<datacite:givenName>Michaela</datacite:givenName>

  
<datacite:familyName>Schlederer</datacite:familyName>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Kenner, Lukas</datacite:creatorName>

  
<datacite:givenName>Lukas</datacite:givenName>

  
<datacite:familyName>Kenner</datacite:familyName>

  
<datacite:nameIdentifier nameIdentifierScheme="ORCID" schemeURI="https://orcid.org/">0000-0003-2184-1338</datacite:nameIdentifier>

  
<datacite:affiliation>University of Veterinary Medicine Vienna</datacite:affiliation>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Weber, Gerhard</datacite:creatorName>

  
<datacite:givenName>Gerhard</datacite:givenName>

  
<datacite:familyName>Weber</datacite:familyName>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Mikulits, Wolfgang</datacite:creatorName>

  
<datacite:givenName>Wolfgang</datacite:givenName>

  
<datacite:familyName>Mikulits</datacite:familyName>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Halbritter, Florian</datacite:creatorName>

  
<datacite:givenName>Florian</datacite:givenName>

  
<datacite:familyName>Halbritter</datacite:familyName>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Moriggl, Richard</datacite:creatorName>

  
<datacite:givenName>Richard</datacite:givenName>

  
<datacite:familyName>Moriggl</datacite:familyName>

  
<datacite:nameIdentifier nameIdentifierScheme="ORCID" schemeURI="https://orcid.org/">0000-0003-0918-9463</datacite:nameIdentifier>

  
<datacite:affiliation>University of Veterinary Medicine Vienna</datacite:affiliation>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Kovar, Heinrich</datacite:creatorName>

  
<datacite:givenName>Heinrich</datacite:givenName>

  
<datacite:familyName>Kovar</datacite:familyName>

  
</datacite:creator>

  
</datacite:creators>

  
<dc:publisher>Cell Press</dc:publisher>

  
<resourceType resourceTypeGeneral="literature" uri="http://purl.org/coar/resource_type/c_6501">journal article</resourceType>

  
<datacite:rights rightsURI="http://purl.org/coar/access_right/c_abf2">open access</datacite:rights>

  
<dc:language>eng</dc:language>

  
<dc:description xml:lang="en">Ewing sarcoma (EwS) is an aggressive cancer of adolescents in need of effective treatment. Insulin-like growth factor (IGF)-1 is an autocrine growth factor for EwS, but only 10% of patients respond to IGF-1 receptor (IGF-1R) blockade. Although EwS is presumed to originate from mesenchymal progenitors during bone development, targeting of the EwS driver oncogene EWS::FLI1 to the mesenchymal lineage in a mouse model does not result in tumor formation but in skeletal malformations and perinatal death. We report that transient exposure to IGF-1 concentrations mimicking serum levels during puberty reprograms limb-derived mesenchymal cells of EWS::FLI1-mutant mice to stable transformation and tumorigenicity. We identify a modular mechanism of IGF-1-driven tumor promotion in the early steps of EwS pathogenesis, in which Yap1 plays a central role. Pharmacologic Yap1/Tead inhibition reverses the transformed phenotype of EWS::FLI1-expressing cells. Our data provide a rationale for combined IGF-1R and YAP/TEAD inhibition in the treatment of EwS patients.</dc:description>

  
<datacite:subjects>
  
<datacite:subject xml:lang="en">Animals</datacite:subject>

  
<datacite:subject xml:lang="en">Mesenchymal Stem Cells Metabolism</datacite:subject>

  
<datacite:subject xml:lang="en">YAP-Signaling Proteins Metabolism</datacite:subject>

  
<datacite:subject xml:lang="en">RNA-Binding Protein EWS Metabolism</datacite:subject>

  
<datacite:subject xml:lang="en">RNA-Binding Protein EWS Genetics</datacite:subject>

  
<datacite:subject xml:lang="en">Humans</datacite:subject>

  
<datacite:subject xml:lang="en">Mice</datacite:subject>

  
<datacite:subject xml:lang="en">Cell Transformation, Neoplastic Metabolism</datacite:subject>

  
<datacite:subject xml:lang="en">Cell Transformation, Neoplastic Genetics</datacite:subject>

  
<datacite:subject xml:lang="en">Proto-Oncogene Protein c-fli-1Metabolism</datacite:subject>

  
<datacite:subject xml:lang="en">Proto-Oncogene Protein c-fli-1Genetics</datacite:subject>

  
<datacite:subject xml:lang="en">Adaptor Proteins, Signal Transducing Metabolism</datacite:subject>

  
<datacite:subject xml:lang="en">Insulin-Like Growth Factor I Metabolism</datacite:subject>

  
<datacite:subject xml:lang="en">Transcription Factors Metabolism</datacite:subject>

  
<datacite:subject xml:lang="en">Sarcoma, Ewing Metabolism</datacite:subject>

  
<datacite:subject xml:lang="en">Sarcoma, Ewing Pathology</datacite:subject>

  
<datacite:subject xml:lang="en">Sarcoma, Ewing Genetics</datacite:subject>

  
<datacite:subject xml:lang="en">Cellular Reprogramming Drug Effects</datacite:subject>

  
<datacite:subject xml:lang="en">Oncogene Proteins, Fusion Metabolism</datacite:subject>

  
<datacite:subject xml:lang="en">Oncogene Proteins, Fusion Genetics</datacite:subject>

  
<datacite:subject xml:lang="en">Receptor, IGF Type 1 Metabolism</datacite:subject>

  
<datacite:subject xml:lang="en">Bone and Bones Metabolism</datacite:subject>

  
<datacite:subject xml:lang="en">Bone and Bones Pathology</datacite:subject>

  
</datacite:subjects>

  
<licenseCondition uri="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</licenseCondition>

  
<file accessRightsURI="http://purl.org/coar/access_right/c_abf2" mimeType="application/pdf" objectType="fulltext">https://phaidra.vetmeduni.ac.at/api/object/o:4046/download</file>

  
<datacite:alternateIdentifiers>
  
<datacite:alternateIdentifier alternateIdentifierType="DOI">10.1016/j.celrep.2025.115381</datacite:alternateIdentifier>

  
</datacite:alternateIdentifiers>

  
<datacite:relatedIdentifiers>
  
<datacite:relatedIdentifier relatedIdentifierType="URL" relationType="IsPartOf">https://phaidra.vetmeduni.ac.at/o:605</datacite:relatedIdentifier>

  
</datacite:relatedIdentifiers>

  
<dc:format>application/pdf</dc:format>

  
<dc:source xml:lang="en">Cell Reports</dc:source>

  
<dc:source>issn:1746-6148</dc:source>

  
<version uri="http://purl.org/coar/version/c_970fb48d4fbd8a85">VoR</version>

  
<citationTitle>Cell Reports</citationTitle>

  
<citationVolume>44</citationVolume>

  
<citationIssue>3</citationIssue>

  
<datacite:sizes>
  
<datacite:size>5.31 MB</datacite:size>

  
</datacite:sizes>

  
<datacite:dates>
  
<datacite:date dateType="Issued">2025</datacite:date>

  
</datacite:dates>

  
</resource>


